Enzymatic cofactor

An enzymatic cofactor is a non-protein chemical component, either an inorganic metal ion or a complex organic molecule (coenzyme), essential for the catalytic activity of an enzyme (StatPearls, 2023). These molecules bind to the inactive protein part (apoenzyme) to create a catalytically active holoenzyme, often participating directly in the reaction by transferring electrons, atoms, or functional groups (NIH, 2024). While essential for health, "enzymatic cofactor" is a broad functional category rather than a specific therapeutic target (Wikipedia, 2024). Many drugs act by mimicking, inhibiting, or supplementing specific cofactors to modulate enzyme activity in diseases such as metabolic disorders or cancer (PubMed, 2022). For example, Sapropterin is a synthetic version of the cofactor tetrahydrobiopterin used to treat phenylketonuria, while Methotrexate interferes with folate cofactor metabolism to inhibit cell proliferation (FDA, 2007; PubMed, 2021). The therapeutic utility of cofactors spans from simple nutritional supplementation to complex targeted therapies in oncology and metabolic medicine. Understanding the specific cofactor requirements of an enzyme is crucial for drug design, as many inhibitors are designed to compete with these essential molecules.

Other names

CofactorCoenzymeProsthetic groupCosubstrateMetal ion cofactor

Cofactors bind to apoenzymes to form functional holoenzymes, facilitating chemical transformations such as redox reactions or group transfers that the protein component alone cannot perform (StatPearls, 2023). Therapeutic strategies include cofactor replacement to treat deficiencies or competitive inhibition to block pathological enzymatic activity (PubMed, 2021).